OPRL1

Across TCGA pan-cancer cohorts, OPRL1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated OPRL1 data layer compared with 22 for mass-spec protein and 8 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher OPRL1 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated OPRL1 expression acts as an unfavorable survival marker, although some lineages such as LUAD and CCRCC show a favorable association.

LUAD, LSCC, and CCRCC are the cancer types where OPRL1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	II,III,IV	0.781	0.232	.001	43	view →
LSCC	OS	Quartile	II,III,IV	0.591	0.938	.017	15	view →
CCRCC	DFS	Tertile	III,IV	1.000	0.811	.025	4	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

OPRL1–LUAD (DFS)

Open the LUAD breakdown →